What is the current Price Target for the NewAmsterdam Pharma Company stock?

The average NewAmsterdam Pharma Company target price is $43.86. This is 21.70% higher than the current stock price. The highest price target is 45.67%, the lowest is -24.33%. 14 Analysts have issued a price target NewAmsterdam Pharma Company 2026 .

How high will the NewAmsterdam Pharma Company stock rise?

No reliable answer can be given as to how high the NewAmsterdam Pharma Company stock will rise. The performance of stocks, including the NewAmsterdam Pharma Company stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the NewAmsterdam Pharma Company stock today?

The performance of NewAmsterdam Pharma Company stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the NewAmsterdam Pharma Company stock fall?

The decline in NewAmsterdam Pharma Company stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

NewAmsterdam Pharma Company Forecast, price target & analysts

$36.04

0.90% yesterday

Nasdaq, Oct 27, 09:00 pm CET

ISIN

NL00150012L7

Symbol

NAMS

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

NewAmsterdam Pharma Company Target price 2025 - Analyst rating & recommendation

NewAmsterdam Pharma Company Classifications & Recommendation:

Buy

89%

Hold

11%

NewAmsterdam Pharma Company Price Target

Target Price	$43.86
Price	$36.04
Potential	21.70% register free of charge
Number of Estimates	14

	14 Analysts have issued a price target NewAmsterdam Pharma Company 2026 . The average NewAmsterdam Pharma Company target price is $43.86. This is 21.70% register free of charge higher than the current stock price. The highest price target is $52.50 45.67% register free of charge , the lowest is $27.27 24.33% register free of charge .
	A rating was issued by 19 analysts: 17 Analysts recommend NewAmsterdam Pharma Company to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the NewAmsterdam Pharma Company stock has an average upside potential 2026 of 21.70% register free of charge . Most analysts recommend the NewAmsterdam Pharma Company stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '22	2023 Estimates
Earnings Per Share $	-0.95	-2.21
	495.83%	132.63%
P/E		negative
EV/Sales		277.33

Based on analysts' sales estimates for 2023, the NewAmsterdam Pharma Company stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	34.33	167.16%
2023	277.33 707.83% Unlock
2024	112.68 59.37% Unlock
2025	120.99 7.38% Unlock
2026	119.01 1.64% Unlock
2027	26.24 77.95% Unlock
2028	11.77 55.15% Unlock
2029	6.34 46.09% Unlock
2030	3.83 39.56% Unlock
2031	2.78 27.43% Unlock
2032	2.34 16.02% Unlock

Current	37.91	130.70%
2023	306.26 707.76% Unlock
2024	124.43 59.37% Unlock
2025	133.61 7.38% Unlock
2026	131.42 1.64% Unlock
2027	28.97 77.95% Unlock
2028	12.99 55.15% Unlock
2029	7.01 46.09% Unlock
2030	4.23 39.56% Unlock
2031	3.07 27.43% Unlock
2032	2.58 16.02% Unlock

NewAmsterdam Pharma Company...

Current NewAmsterdam Pharma Company Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Citigroup	Locked ➜ Locked	Locked	Oct 17 2025
Wells Fargo	Locked ➜ Locked	Locked	Aug 25 2025
RBC Capital	Locked ➜ Locked	Locked	Aug 07 2025
Goldman Sachs	Locked ➜ Locked	Locked	Jul 17 2025
Citigroup	Locked ➜ Locked	Locked	Jun 17 2025
Needham	Locked ➜ Locked	Locked	Jun 12 2025
Stifel	Locked ➜ Locked	Locked	Jun 10 2025

Analyst Rating	Date
Locked Citigroup: Locked ➜ Locked	Oct 17 2025
Locked Wells Fargo: Locked ➜ Locked	Aug 25 2025
Locked RBC Capital: Locked ➜ Locked	Aug 07 2025
Locked Goldman Sachs: Locked ➜ Locked	Jul 17 2025
Locked Citigroup: Locked ➜ Locked	Jun 17 2025
Locked Needham: Locked ➜ Locked	Jun 12 2025
Locked Stifel: Locked ➜ Locked	Jun 10 2025

Discover more stocks with a high price target

TUI 50.52%

Deutsche Telekom 33.66%

Netflix 32.33%

Novo Nordisk 32.00%

BioNTech SE - ADR 31.77%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now